Chemoinformaics analysis of Mercapto-p-menthan-3-one, cis-
| Molecular Weight | 186.32 | nRot | 1 |
| Heavy Atom Molecular Weight | 168.176 | nRig | 7 |
| Exact Molecular Weight | 186.108 | nRing | 1 |
| Solubility: LogS | -1.713 | nHRing | 0 |
| Solubility: LogP | 1.952 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 32.4043 |
| nHD | 1 | BPOL | 21.3857 |
| QED | 0.623 |
| Synth | 4.331 |
| Natural Product Likeliness | 1.782 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.005 |
| CACO-2 | -4.285 |
| MDCK | 0.0000203 |
| BBB | 0.235 |
| PPB | 0.95936 |
| VDSS | 1.25 |
| FU | 0.0710004 |
| CYP1A2-inh | 0.05 |
| CYP1A2-sub | 0.48 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.888 |
| CYP2c9-inh | 0.05 |
| CYP2c9-sub | 0.373 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.236 |
| CYP3a4-inh | 0.131 |
| CYP3a4-sub | 0.427 |
| CL | 16.08 |
| T12 | 0.623 |
| hERG | 0.008 |
| Ames | 0.006 |
| ROA | 0.185 |
| SkinSen | 0.206 |
| Carcinogencity | 0.904 |
| EI | 0.189 |
| Respiratory | 0.063 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.930817 |